Urinary tract infections (UTI) are among the most common bacterial infections, worldwide. UTI are primarily caused by uropathogenic Escherichia coli (UPEC). With antibiotic resistance on the rise, understanding how these bacteria survive in the hostile environment of the urinary tract and how they can be eliminated has become critical. This collaborative study from teams at Institut Cochin & Institut Pasteur and the Max Planck Institute for Infection Biology discovered a sophisticated bacterial "sensor system" that allows UPEC to detect and disarm key human immune defenses.

The body's frontline defense against UPEC involves neutrophils - white blood cells that deploy sticky, web-like structures called neutrophil extracellular traps (NETs) to capture and kill bacteria. NETs are composed of DNA decorated with antimicrobial proteins packaged as nucleosomes. Nucleosomes are complex three-dimensional structures composed of histone proteins with DNA wrapped around them. While NETs are potent weapons, the researchers discovered that UPEC have a specific two-gene system they named DanRI (Defense against Neutrophil Regulator and Inhibitor), that detects these nucleosomes and triggers a protective response inside the bacteria. Epidemiological analysis revealed that DanRI is present in approximately 29% of UPEC clinical isolates - particularly in antibiotic-resistant lineages such as ST73 and ST131 - but is rare in other E. coli types. This suggests DanRI is a specialized pathogenic adaptation for the urinary tract niche.

The DanRI system is composed of two genes: danR, which regulates DNA-binding, and danI, encoding an inhibitor protein. When nucleosomes or histone H3 contact the bacterium, they activate both genes, causing their expression to increase. The DanR protein functions as a transcriptional repressor of various bacterial pathways. However, when DanI is produced simultaneously, it binds to and inhibits DanR. This regulatory interplay reconfigures bacterial physiology - suppressing flagellar synthesis, altering metabolic processes, and activating stress responses - to optimize survival under hostile conditions. Functionally, this system acts as a "dimmer switch" on the host immune response. In laboratory experiments with human neutrophils, UPEC lacking DanRI triggered significantly stronger production of toxic reactive oxygen species and induced more NET formation than normal UPEC. By dampening these aggressive neutrophil responses, the intact DanRI system allows bacteria to survive longer and establish infection.

The clinical significance of this mechanism was confirmed in mouse models. While UPEC with or without DanRI could initially colonize the bladder equally well, mutant bacteria lacking the system were eliminated more effectively after 2 days. This enhanced clearance resulted from an increased inflammatory environment. Without DanRI, infected bladders showed elevated levels of cytokines and chemokines, molecules that drive an immune response, including calling neutrophils and monocytes to the infection. Notably, DanRI still provided a fitness advantage even in mice genetically unable to produce oxidative bursts, confirming that its primary role is to suppress inflammation broadly rather than merely protecting against direct oxidative killing.

In summary, this study identifies DanRI as a critical immune evasion tool that allows UPEC to sense attack via NET components and respond by dampening host inflammation – essentially turning down the heat. Therapeutically, disrupting this sensing system could reinvigorate the immune response against UPEC, offering a potential new strategy to combat recurrent UTI without relying solely on antibiotics.